Quincy Bioscience began as a company with primarily pharmaceutical aspirations and has now branched into dietary supplements because of the laboratory success of apoaequorin and the applicability of our technology to meet the needs of our aging population. Following is a brief summary of those major events and milestones that have transpired since the beginning…

History

Quincy Bioscience officially started this journey on June 7, 2004, just a few short days after the passing of President Reagan, a time when the nation’s attention turned to Alzheimer’s and its destructive course of events. Quincy Bioscience remains motivated to make a difference in the quality of life for those afflicted with the diseases of aging and also for those that want to fight the aging process through preventative measures. As President Reagan noted on a plaque that sat on his Oval Office desk...It Can Be Done!

Quincy Bioscience opened headquarters in the University Research Park in the fall of 2004. Simultaneously, a partnership was formed with the laboratory of Dr. James R. Moyer, Jr. of the University of Wisconsin at Milwaukee. Dr. Moyer is a leading expert in the field of calcium-mediated dementia and cellular death. Our work with the Moyer laboratory continues to be fruitful and Quincy Bioscience is seeking to replicate this model of success with other academic laboratories with other product development specialties.

Quincy Bioscience looks forward to a healthy future of innovation in therapeutics and other technologies to help fight the aging process.